Provenance du réseau au premier degré de Jeffrey Bartlett
Entité | Type d'entité | Industrie | |
---|---|---|---|
Rampart Bioscience, Inc.
Rampart Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services The American company is focused on developing non-viral gene medicines for patients with genetically driven diseases. The company integrates capabilities from various scientific disciplines to create optimized therapeutics in a redosable, non-viral format. The company's proprietary development and delivery platforms are designed to achieve higher standards for potency, durability, redosability, and safety. Rampart Bioscience is committed to realizing the potential of gene therapy to provide safe, long-lasting treatments for a wide range of diseases. The company's culture is built on the tenets of authenticity, integrity, and personal freedom, and they are working together to achieve audacious goals. The company was founded by Louis Breton and Jeffrey Bartlett, and Louis Breton has been the CEO since incorporation.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jeffrey Bartlett via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Calimmune, Inc. operates as a clinical-stage biotechnology company. The firm offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. The company was founded by David Baltimore, Inder M. Verma, Irvin Chen and Louis Breton in 2006 and is headquartered in Tucson, AZ. | Biotechnology | Founder |
Statistiques
Internationale
Etats-Unis | 3 |
Sectorielle
Commercial Services | 2 |
Health Technology | 2 |
Opérationnelle
Founder | 3 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
President | 1 |
Relations les plus connectées
Insiders | |
---|---|
Louis Breton | 3 |
- Bourse
- Insiders
- Jeffrey Bartlett
- Connexions Sociétés